150
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Pathogenic Spectrum and Resistance Pattern of Bloodstream Infections Isolated from Postpartum Women: A Multicenter Retrospective Study

, , , , ORCID Icon, , & show all
Pages 2387-2395 | Published online: 25 Jun 2021

References

  • Van Dillen J, Zwart J, Schutte J, et al. Maternal sepsis: epidemiology, etiology and outcome. Curr Opin Infect Dis. 2010;23(3):249–254. doi:10.1097/QCO.0b013e328339257c20375891
  • McCaw-Binns AM, Campbell LV, Spence SS. The evolving contribution of non-communicable diseases to maternal mortality in Jamaica, 1998–2015: a population-based study. BJOG. 2018;125(10):1254–1261. doi:10.1111/1471-0528.1515429419921
  • Hirshberg A, Srinivas SK. Epidemiology of maternal morbidity and mortality. Semin Perinatol. 2017;41(6):332–337. doi:10.1053/j.semperi.2017.07.00728823579
  • Lapinsky SE. Obstetric infections. Crit Care Clin. 2013;29(3):509–520. doi:10.1016/j.ccc.2013.03.00623830651
  • Goto M, Al-Hasan M. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501–509. doi:10.1111/1469-0691.1219523473333
  • Yang ZY, Zhan SY, Wang B, et al. Fatality and secular trend of bloodstream infections during hospitalization in China. Beijing Da Xue Bao Yi Xue Ban. 2010;42(3):304–307.
  • Bebell LM, Ngonzi J, Bazira J, et al. Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital. PLoS One. 2017;12(4):e0175456. doi:10.1371/journal.pone.017545628406949
  • Zhang X, Gu B, Mei Y, et al. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004–2011. J Antibiotics. 2015;68(2):115–120. doi:10.1038/ja.2014.119
  • Gopalakrishnan R, Sureshkumar D. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme. J Assoc Physicians India. 2010;58(Suppl):25–31.21563610
  • Jorak A, Keihanian F, Saeidinia A, et al. A cross sectional study on knowledge, attitude and practice of medical students toward antibiotic resistance and its prescription, Iran. Adv Environ Biol. 2014;8(17):675–681.
  • Humphries RM, Abbott AN, Hindler JA. Understanding and addressing CLSI breakpoint revisions: a primer for clinical laboratories. J Clin Microbiol. 2019;57(6):e00203–19. doi:10.1128/JCM.00203-1930971460
  • Arendrup MC, Friberg N, Mares M, et al. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2020:26(11):1464-1472. doi:10.1016/j.cmi.2020.06.007.
  • Yangco B. CDC definitions for nosocomial infections. Am J Infect Control. 1989;17(1):42–43. doi:10.1016/S0196-6553(89)80013-62538096
  • Chen YB, Ji JR, Ying CQ, et al. BRICS report of 2016–2017: the distribution and antimicrobial resistance profile of clinical isolates from blood culture in China. Chin J Clin Infect Dis. 2020;13(01):42–54.
  • Musicha P, Cornick JE, Bar-Zeev N, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042–1052. doi:10.1016/S1473-3099(17)30394-828818544
  • Habyarimana T, Murenzi D, Musoni E, et al. Bacteriological profile and antimicrobial susceptibility patterns of bloodstream infection at Kigali University Teaching Hospital. Infect Drug Resist. 2021;23(14):699–707. doi:10.2147/IDR.S299520
  • Diekema DJ, Beekmann SE, Chapin KC, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003;41(8):3655–3660. doi:10.1128/JCM.41.8.3655-3660.200312904371
  • Blairon L, De Gheldre Y, Delaere B, et al. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect. 2006;12(6):527–532. doi:10.1111/j.1469-0691.2006.01407.x16700700
  • Khan I, Yasir M, Farman M, et al. Evaluation of gut bacterial community composition and antimicrobial resistome in pregnant and non-pregnant women from Saudi population. Infect Drug Resist. 2019;12:1749–1761. doi:10.2147/IDR.S20021331417292
  • Gajdács M, Terhes G, Urbán E. Az anaerob baktériumok által okozott véráramfertőzések gyakorisága 2005–2009 és 2013–2017 között egy egyetemi központban. Retrospektív összehasonlító vizsgálat [The incidence of bloodstream infections caused by anaerobic bacteria in a university hospital between 2005–2009 and 2013–2017. A retrospective, comparative study]. Orv Hetil. 2020;161(19):797–803. doi:10.1556/650.2020.3170532364362
  • Cobo F, Borrego J, Gómez E, et al. Clinical findings and antimicrobial susceptibility of anaerobic bacteria isolated in bloodstream infections. Antibiotics (Basel). 2020;9(6):345. doi:10.3390/antibiotics9060345
  • Redelinghuys MJ, Ehlers MM, Dreyer AW, et al. Normal flora and bacterial vaginosis in pregnancy: an overview. Crit Rev Microbiol. 2016;42(3):352–363. doi:10.3109/1040841X.2014.95452225834920
  • Brabant G. Vaginose bactérienne et prématurité spontanée [Bacterial vaginosis and spontaneous preterm birth]. J Gynecol Obstet Biol Reprod (Paris). 2016;45(10):1247–1260. doi:10.1016/j.jgyn.2016.09.01427793493
  • Subtil D, Brabant G, Tilloy E, et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet. 2018;392(10160):2171–2179. doi:10.1016/S0140-6736(18)31617-930322724
  • Soper DE. Bacterial vaginosis and surgical site infections. Am J Obstet Gynecol. 2020;222(3):219–223. doi:10.1016/j.ajog.2019.09.00231499057
  • Shrivastava SR, Shrivastava PS, Ramasamy J. Responding to the challenge of antibiotic resistance: World Health Organization. J Res Med Sci. 2018;23:21. doi:10.4103/1735-1995.22859329692818
  • Nicoloff H, Hjort K, Levin BR, et al. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat Microbiol. 2019;4(3):504–514. doi:10.1038/s41564-018-0342-030742072
  • Sun JD, Huang SF, Yang SS, et al. Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. Clin Microbiol Infect. 2015;21(5):469.e1–10. doi:10.1016/j.cmi.2014.12.013
  • Band VI, Crispell EK, Napier BA, et al. Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nat Microbiol. 2016;1(6):16053. doi:10.1038/nmicrobiol.2016.5327572838
  • ACOG Practice Bulletin No. 199: use of prophylactic antibiotics in labor and delivery: correction. Obstet Gynecol. 2018;132(3):e103-e119. Erratum in Obstet Gynecol. 2019;134(4):883–884. doi:10.1097/AOG.0000000000003499
  • Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev. 2014;2014(10):CD007482.
  • Rubin H, Rom E, Wattad M, et al. Effectiveness of antimicrobial prophylaxis at 30 versus 60 min before cesarean delivery. Sci Rep. 2021;11(1):8401. doi:10.1038/s41598-021-87846-z33863969